FDA-Approved Immune Therapy Shows Benefit in Newly Diagnosed
In a Breakthrough T1D-funded clinical trial and published in the New England Journal of Medicine, baricitinib preserved beta cell function in type 1 diabetes.
ISPAD Annual Conference Highlights Include Tzield, Kidney Disease Clinical Trial Updates
Leading diabetes researchers gathered for the annual ISPAD conference. More than 45 studies were presented by Breakthrough T1D researchers, including Tzield.
Results Are Out: Tzield Benefits Newly Diagnosed Individuals
A new study published in the New England Journal of Medicine shows Tzield can preserve beta cell health in certain individuals recently diagnosed with T1D.
Insulin resistance and type 1 diabetes
We take a closer look at what insulin resistance is, the risks associated with it for people with type 1 diabetes, and the latest research to address it.
Top Diabetes Researchers Gather for the ISPAD Annual Conference
Leading researchers from around the world will gather for the ISPAD annual conference, with more than 45 studies presented by Breakthrough T1D-funded researchers.
EASD Meeting Brought Together World-Renowned Minds in Diabetes Research
Leading researchers gathered for the annual meeting of the European Association for the Study of Diabetes (EASD), which took place from October 2-6.
Top Researchers Gather for the EASD Annual Meeting
Leading researchers will gather for the annual meeting of the European Association for the Study of Diabetes, with 65 presentations by Breakthrough T1D researchers.
ADCES Meeting Brings Together Health Care Specialists in Diabetes
The Association of Diabetes Care & Education Specialists (ADCES) meeting took place August 4-7, 2023, to address key issues affecting people with diabetes.
ADA’s Scientific Sessions: Takeaways Day 3
The American Diabetes Association’s conference will hear scientists present the latest research, all with the goal of improving lives for the T1D community.
